Equities

Nanalysis Scientific Corp

Nanalysis Scientific Corp

Actions
  • Price (CAD)0.38
  • Today's Change0.005 / 1.33%
  • Shares traded2.87k
  • 1 Year change-11.63%
  • Beta0.7128
Data delayed at least 15 minutes, as of Nov 14 2024 20:47 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CAD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments0.763.5310
Total Receivables, Net9.768.986.10
Total Inventory5.797.393.68
Prepaid expenses1.602.060.58
Other current assets, total------
Total current assets182221
Property, plant & equipment, net4.746.422.54
Goodwill, net5.70130.39
Intangibles, net162714
Long term investments5.73----
Note receivable - long term0.690.77--
Other long term assets------
Total assets547038
LIABILITIES
Accounts payable------
Accrued expenses------
Notes payable/short-term debt2.902.600.23
Current portion long-term debt/capital leases4.381.841.97
Other current liabilities, total2.233.312.01
Total current liabilities15148.65
Total long term debt156.313.79
Total debt22115.99
Deferred income tax0.180.260.26
Minority interest012--
Other liabilities, total0.882.261.14
Total liabilities303514
SHAREHOLDERS EQUITY
Common stock534931
Additional paid-in capital4.673.091.64
Retained earnings (accumulated deficit)(35)(19)(9.69)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.601.820.71
Total equity233524
Total liabilities & shareholders' equity547038
Total common shares outstanding1029477
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.